We’re thrilled to welcome Dr. Jenifer Sheehy and Eric Garcia at our upcoming free webinar on Tuesday, June 18 at 10 a.m. PT/1 p.m. ET. Dr. Sheehy’s expertise in clinical pharmacology and Eric Garcia’s digital marketing experience will help you increase parasite prevention with home delivery and ensure clients are on top of their pet’s recommended care. You don’t want to miss this! https://lnkd.in/ggffJjht
Vetsource’s Post
More Relevant Posts
-
Interesting opportunity for chemicals risk assessors to get up to date on hormone disruption by chemicals.
📣 #Registrations are now open! 📣 ECETOC and Regulatory Science Associates are thrilled to invite you to register for our upcoming symposium: #Testing, #Assessment, and #Classification of #Thyroid #Hormone #Disruptors 🧪 📅 Date: 8 September 2024 📍 Location: Copenhagen 🕛 Time: 12:00 PM - 4:15 PM Join us for this independently-organised satellite event of the EUROTOX Congress 2024, where we will bring together regulatory toxicologists, (clinical) pathologists, and experts from European regulatory authorities to: - Review the state of the science, - Discuss its current application in regulatory decision-making, - Propose future options for evaluating thyroid hormone-related neurodevelopmental toxicity. 📋 Browse the #agenda and #register below ⬇ - Space is limited and on a first-come, first-served basis! We look forward to seeing you in Copenhagen! 🌟
-
And here is someone who is paving the future of #precisionmedicine: Virginia Savova, Ph. D. Savova talks about medicine with cellular precision and the value of single-cell data in drug development at #TriCon Precision Medicine!
-
-
Reposting an insightful podcast episode from Mayo Clinic Laboratories that's perfect for those short on time. In just 12 minutes, this discussion provides some background on the FDA's proposed regulation of Laboratory Developed Tests (LDTs) and shares insights on how you can engage and make your voice heard on this crucial issue. Whether you're for or against the proposal, check it out and join the conversation. Your perspective and actions could play a crucial role in shaping the future of LDT regulations. #LDTs #LaboratoryMedicine
In this episode of “Answers From the Lab,” Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and Bill Morice, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss the U.S. Food and Drug Administration’s (FDA) recently proposed rule that if finalized, would phase out its current enforcement discretion used for laboratory developed tests, and regulate all laboratory tests as medical devices regardless of where they are manufactured. https://bit.ly/3LKRfYr
-
Are you attending ASCPT? Reach out to Cody Mann to explore how Certara can best support and accelerate your drug development process or needs.
Are you attending #ASCPT2024? Join us for a Lunch & Learn with Certara's S. Y. Amy Cheung and Mark Shelton as they offer insights into our wide-ranging Cardiac Assessment support, featuring expertise from clinical pharmacologists, pharmacometricians, toxicologists, and cardiologists. Learn more: https://lnkd.in/dUPfxTUs
ASCPT 2024 Annual Meeting
https://www.certara.com
-
Senior Sales Manager at Aegis helping reduce human tragedy thru harm reduction and accurate lab testing for Xylazine and the latest synthetic street drugs.
Clinical update webinar 6/25 great way to gain information around toxicology testing, harm reduction and identifying potential drug abuse.
Some healthcare laboratories are starting to expand Novel Psychoactive Substance or NPS testing, even adding some of the fentanyl analogs to their offering, but Aegis has purposefully explored addition of relevant nitazene compounds within our designer opioid menu to ensure we are offering relevant testing. Join us on Tuesday, June 25th, for our monthly clinical webinar presented by Dr. Holt as we discuss new data on nitazenes and ongoing evaluation of this emerging threat. Register Today: https://lnkd.in/ejtCHFuc #AegisLabs #Nitazenes #DesignerOpioids #NPS #OnePillCanKill #PublicSafety #Webinar #LivePresentation #Clinical #Education
-
THIS is one of our many “whys” we do what we do. Substance Use Disorder is the public health crisis of our time. It is critical for clinicians AND patients to “be in the know” & have a comprehensive objective understanding of substances that are being used and/or abused. Education is power & will lead to better outcomes for human lives ! How is your lab partner educating you on current trends?! #AegisEducates
Some healthcare laboratories are starting to expand Novel Psychoactive Substance or NPS testing, even adding some of the fentanyl analogs to their offering, but Aegis has purposefully explored addition of relevant nitazene compounds within our designer opioid menu to ensure we are offering relevant testing. Join us on Tuesday, June 25th, for our monthly clinical webinar presented by Dr. Holt as we discuss new data on nitazenes and ongoing evaluation of this emerging threat. Register Today: https://lnkd.in/ejtCHFuc #AegisLabs #Nitazenes #DesignerOpioids #NPS #OnePillCanKill #PublicSafety #Webinar #LivePresentation #Clinical #Education
-
🙌 The BD FACSMelody™ provides you with some much-needed flexibility within your research. You will have the ability to separate out up to 4 populations into individual test tubes or 1 population into plates from 6 to 384 wells. Hear from Reiner Schulte about how these features help his core facility. To watch the full video, or to learn more about how the BD FACSMelody™ can support your research click here: 👉 https://lnkd.in/eygQdK6e For Research Use Only. Not for use in diagnostic or therapeutic procedures. #CellSorting #FlowCytometry #BDBiosciences
